山东大学教师主页刘发保 HDAC11 Inhibition as a Potential Therapeutic Strategy for AML: Target Identification, Lead Discovery, Antitumor Potency, and Mechanism Investigation Home

Home > Scientific Research > Paper Publications

HDAC11 Inhibition as a Potential Therapeutic Strategy for AML: Target Identification, Lead Discovery, Antitumor Potency, and Mechanism Investigation

Release Time:2025-05-17 Hits:

Institution:医学融合与实践中心
Journal:Journal of Medicinal Chemistry
Document Code:1915344237513039874
Number of Words:1
Translation or Not:No
Date of Publication:2025-04

Prev One:Dual targeting PPARα and NPC1L1 metabolic vulnerabilities blocks tumorigenesis

Next One:Discovery of epigenetic modulators targeting HDACs and EZH2 simultaneously for the treatment of hematological malignancies

Home

Scientific Research

Teaching Research

Awards and Honours

Enrollment Information

Student Information

My Album

Blog

Personal Information

HDAC11 Inhibition as a Potential Therapeutic Strategy for AML: Target Identification, Lead Discovery, Antitumor Potency, and Mechanism Investigation